NATALIE BLAND: Open Payments
NPI 1205370079 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 14 payments from 11 companies in 2025. Trend: 2023 $571 · 2024 $384 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 1 | $136 |
| Corcept Therapeutics | 1 | $89 |
| Lilly USA, LLC | 2 | $55 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Indivior Inc. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Exact Sciences Corporation | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| ViiV Healthcare Company | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: BRIXADI, Korlym, MOUNJARO, SHINGRIX, SUBLOCADE, INGREZZA, Cologuard Collection Kit, APRETUDE.
Industry payments across CA — which companies pay providers there.
